Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Psychopharmacology (Berl) ; 238(4): 1171-1181, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33506304

RESUMEN

RATIONALE: There is strong evidence that nicotine can enhance cognitive functions and growing evidence that this effect may be larger in young healthy APOE ε4 carriers. However, the moderating effects of the APOE ε4 allele on cognitive impairments caused by nicotine deprivation in chronic smokers have not yet been studied with brain indices. OBJECTIVE: We sought to determine whether young female carriers of the APOE ε4 allele, relative to noncarriers, would exhibit larger abstinence-induced decreases in P3b amplitude during a two-stimulus auditory oddball task. METHODS: We compared parietal P3bs in female chronic smokers with either APOE ε3/ε3 (n = 54) or ε3/ε4 (n = 20) genotype under nicotine-sated conditions and after 12-17-h nicotine deprivation. RESULTS: Nicotine deprivation significantly reduced P3b amplitudes in APOE ε4 carriers, but not in APOE-ε3/ε3 individuals, such that the difference seen prior to nicotine deprivation was eliminated. CONCLUSIONS: The results suggest that subjects with the APOE ε4 allele are more sensitive to nicotine, which could influence smoking patterns, the risk for nicotine dependence, and the cognitive effects of nicotine use in these individuals.


Asunto(s)
Apolipoproteína E3/genética , Electroencefalografía/efectos de los fármacos , Cese del Hábito de Fumar/psicología , Fumar/psicología , Estimulación Acústica , Adulto , Femenino , Genotipo , Heterocigoto , Humanos , Masculino , Nicotina/farmacología , Agonistas Nicotínicos/farmacología , Lóbulo Parietal/fisiopatología , Desempeño Psicomotor/efectos de los fármacos , Fumar/genética , Adulto Joven
2.
Exp Clin Psychopharmacol ; 25(1): 41-49, 2017 02.
Artículo en Inglés | MEDLINE | ID: mdl-28150971

RESUMEN

The mechanisms underlying bupropion's efficacy as an antidepressant and a smoking cessation aid are far from being fully characterized. The present study is the first to examine the effects of bupropion on visuospatial task-related parietal EEG alpha power asymmetry-an asymmetry that has previously been found to be associated with severity of depressive symptoms (i.e., the more depressive symptoms, the greater alpha power in the right vs. left parietal area [Henriques & Davidson, 1997; Rabe, Debener, Brocke, & Beauducel, 2005]). Participants, all of whom were smokers and none of whom were clinically depressed, were randomly assigned to the Placebo group (n = 79) or Bupropion group (n = 31) in a double-blind study. EEG during the performance of the visuospatial task was collected before and after 14 days on placebo or bupropion sustained-release capsules. Relative to the Placebo group, the Bupropion group (especially, the Bupropion subgroup who had a positive right versus left parietal alpha power asymmetry at pretreatment) had a reduction in the parietal alpha asymmetry (driven largely by a decrease in right parietal alpha power). These findings support the hypothesis that bupropion can induce changes in parietal EEG asymmetry that have been shown in previous literature to be associated with a reduction in depressive states and traits. (PsycINFO Database Record


Asunto(s)
Antidepresivos de Segunda Generación/farmacología , Bupropión/farmacología , Electroencefalografía , Fumar/psicología , Adulto , Antidepresivos de Segunda Generación/administración & dosificación , Bupropión/administración & dosificación , Preparaciones de Acción Retardada , Método Doble Ciego , Femenino , Humanos , Masculino , Cese del Hábito de Fumar/métodos , Percepción Visual , Adulto Joven
3.
Neurotoxicology ; 33(5): 1212-8, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22796261

RESUMEN

It is widely recognized that the nature and severity of responses to toxic exposure are age-dependent. Using active avoidance conditioning as the behavioral paradigm, the present study examined the effect of short-term methylmercury (MeHg) exposure on two adult age classes, 1- and 2-year-olds to coincide with zebrafish in relatively peak vs. declining health conditions. In Experiment 1, 2-year-old zebrafish were randomly divided into groups and were exposed to no MeHg, 0.15% ethanol (EtOH), 0.01, 0.03, 0.1, or 0.3 µM of MeHg (in 0.15% ethanol) for 2 weeks. The groups were then trained and tested for avoidance responses. The results showed that older zebrafish exposed to no MeHg or EtOH learned and retained avoidance responses. However, 0.01 µM or higher concentrations of MeHg exposure impaired avoidance learning in a dose-dependent manner with 0.3 µM of MeHg exposure producing death during the exposure period or shortly after the exposure but before the avoidance training. In Experiment 2, 1-year-old zebrafish were randomly divided into groups and were exposed to the same concentrations of MeHg used in Experiment 1 for 2 weeks. The groups were then trained and tested for avoidance responses. The results showed that younger zebrafish exposed to no MeHg, EtOH, or 0.01 µM of MeHg learned and retained avoidance responses, while 0.1 or 0.3 µM of MeHg exposure impaired avoidance learning in a dose-dependent manner. The study suggested that MeHg exposure produced learning impairments at a much lower concentration of MeHg exposure and more severely in older adult compared against younger adult zebrafish even after short exposure times.


Asunto(s)
Envejecimiento , Reacción de Prevención/efectos de los fármacos , Conducta Animal/efectos de los fármacos , Discapacidades para el Aprendizaje/inducido químicamente , Compuestos de Metilmercurio/toxicidad , Factores de Edad , Análisis de Varianza , Animales , Relación Dosis-Respuesta a Droga , Aprendizaje por Laberinto/efectos de los fármacos , Tiempo de Reacción/efectos de los fármacos , Factores de Tiempo , Pez Cebra
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...